{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T21:00:06Z","timestamp":1781125206255,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T00:00:00Z","timestamp":1547510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s41687-018-0090-1","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T08:02:52Z","timestamp":1547539372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Development and adaptation of patient-reported outcome measures for patients who experience itch associated with primary biliary cholangitis"],"prefix":"10.1186","volume":"3","author":[{"given":"Mona L.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Stassek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2438-9009","authenticated-orcid":false,"given":"Steven I.","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish V.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,15]]},"reference":[{"key":"90_CR1","doi-asserted-by":"publisher","unstructured":"Hirschfield, G. M., Dyson, J. K., Alexander, G. J. M., Chapman, M. H., Collier, J., Hubscher, S., et al. (2018). The British Society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut. \n                    https:\/\/doi.org\/10.1136\/gutjnl-2017-315259\n                    \n                  .","DOI":"10.1136\/gutjnl-2017-315259"},{"issue":"1.2","key":"90_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2152\/jmi.64.7","volume":"64","author":"K Tsuneyama","year":"2017","unstructured":"Tsuneyama, K., Baba, H., Morimoto, Y., Tsunematsu, T., & Ogawa, H. (2017). Primary biliary cholangitis: Its pathological characteristics and immunopathological mechanisms. J Med Investig, 64(1.2), 7\u201313.","journal-title":"J Med Investig"},{"key":"90_CR3","doi-asserted-by":"publisher","unstructured":"Lu, M., Zhou, Y., Haller, I.V., Romanelli, R. J., VanWormer, J. J., Rodriguez, C. V., et al. (2017). Increasing prevalence of primary biliary cholangitis and reduced mortality with treatment. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association. doi: \n                    https:\/\/doi.org\/10.1016\/j.cgh.2017.12.033\n                    \n                  .","DOI":"10.1016\/j.cgh.2017.12.033"},{"issue":"6","key":"90_CR4","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1002\/hep.23210","volume":"50","author":"RP Myers","year":"2009","unstructured":"Myers, R. P., Shaheen, A. A., Fong, A., Burak, K. W., Wan, A., Swain, M. G., et al. (2009). Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: A population-based study. Hepatology (Baltimore, MD), 50(6), 1884\u20131892.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"4","key":"90_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1542-3565(03)00134-4","volume":"1","author":"JA Talwalkar","year":"2003","unstructured":"Talwalkar, J. A., Souto, E., Jorgensen, R. A., & Lindor, K. D. (2003). Natural history of pruritus in primary biliary cirrhosis. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association, 1(4), 297\u2013302.","journal-title":"Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association"},{"issue":"1","key":"90_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/hep.26365","volume":"58","author":"GF Mells","year":"2013","unstructured":"Mells, G. F., Pells, G., Newton, J. L., Bathgate, A. J., Buroughs, A. K., Heneghan, M. A., et al. (2013). Impact of primary biliary cirrhosis on perceived quality of life: The UK-PBC national study. Hepatology (Baltimore, MD), 58(1), 273\u2013283.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"1","key":"90_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2340\/00015555-0350","volume":"88","author":"E Rishe","year":"2008","unstructured":"Rishe, E., Azarm, A., & Bergasa, N. V. (2008). Itch in primary biliary cirrhosis: A patients\u2019 perspective. Acta Derm Venereol, 88(1), 34\u201337.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"90_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/flgastro-2015-100618","volume":"7","author":"VS Hegade","year":"2016","unstructured":"Hegade, V. S., Bolier, R., Oude Elferink, R. P., Beuers, U., Kendrick, S., & Jones, D. E. (2016). A systematic approach to the management of cholestatic pruritus in primary biliary cirrhosis. Frontline Gastroenterology, 7(3), 158\u2013166.","journal-title":"Frontline Gastroenterology"},{"issue":"3","key":"90_CR9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1365-2133.2009.09586.x","volume":"162","author":"S Elman","year":"2010","unstructured":"Elman, S., Hynan, L. S., Gabriel, V., & Mayo, M. J. (2010). The 5-D itch scale: A new measure of pruritus. Br J Dermatol, 162(3), 587\u2013593.","journal-title":"Br J Dermatol"},{"issue":"11","key":"90_CR10","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1136\/gut.2005.065862","volume":"54","author":"A Jacoby","year":"2005","unstructured":"Jacoby, A., Rannard, A., Buck, D., Bhala, N., Newton, J. L., James, O. F., et al. (2005). Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis. Gut, 54(11), 1622\u20131629.","journal-title":"Gut"},{"key":"90_CR11","doi-asserted-by":"publisher","unstructured":"Gilchrist, K., & Vallow, S. (2015). Development of electronic diary in patients with primary biliary cirrhosis. Value Health. \n                    https:\/\/doi.org\/10.1016\/j.jval.2015.03.183\n                    \n                  .","DOI":"10.1016\/j.jval.2015.03.183"},{"issue":"1","key":"90_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12876-016-0481-9","volume":"16","author":"VS Hegade","year":"2016","unstructured":"Hegade, V. S., Kendrick, S. F., Dobbins, R. L., Miller, S. R., Richards, D., Storey, J., et al. (2016). BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: Study protocol for a randomised controlled trial. BMC Gastroenterol, 16(1), 71.","journal-title":"BMC Gastroenterol"},{"issue":"10074","key":"90_CR13","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/S0140-6736(17)30319-7","volume":"389","author":"VS Hegade","year":"2017","unstructured":"Hegade, V. S., Kendrick, S. F., Dobbins, R. L., Miller, S. R., Thompson, D., Richards, D., et al. (2017). Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: A double-blind, randomised, placebo-controlled, crossover, phase 2a study. Lancet (London, England), 389(10074), 1114\u20131123.","journal-title":"Lancet (London, England)"},{"key":"90_CR14","doi-asserted-by":"publisher","unstructured":"Houts, C. R., Morlock, R., Blum, S.I., Edwards, M.C., & Wirth, R. J. (2018). Scale development with small samples: A new application of longitudinal item response theory. Qual Life Res: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. \n                    https:\/\/doi.org\/10.1007\/s11136-018-1801-z\n                    \n                  .","DOI":"10.1007\/s11136-018-1801-z"},{"key":"90_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1477-7525-4-79","volume":"4","author":"US Department of Health and Human Services FDA Center for Drug Evaluation and Research; US Department of Health and Human Services FDA Center for Biologics Evaluation and Research; US Department of Health and Human Services FDA Center for Devices and Radiological Health","year":"2006","unstructured":"US Department of Health and Human Services FDA Center for Drug Evaluation and Research; US Department of Health and Human Services FDA Center for Biologics Evaluation and Research; US Department of Health and Human Services FDA Center for Devices and Radiological Health. (2006). Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims: Draft guidance. Health Qual Life Outcomes, 4, 79.","journal-title":"Health Qual Life Outcomes"},{"issue":"8","key":"90_CR16","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1001\/jama.1994.03520080072047","volume":"272","author":"GH Guyatt","year":"1994","unstructured":"Guyatt, G. H., & Cook, D. J. (1994). Health status, quality of life. and the individual JAMA, 272(8), 630\u2013631.","journal-title":"and the individual JAMA"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-018-0090-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s41687-018-0090-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-018-0090-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T19:06:07Z","timestamp":1579028767000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpro.springeropen.com\/articles\/10.1186\/s41687-018-0090-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,15]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["90"],"URL":"https:\/\/doi.org\/10.1186\/s41687-018-0090-1","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,15]]},"assertion":[{"value":"3 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AVJ is an employee of and holds equity stock in GlaxoSmithKline (GSK); SIB is a former employee of and holds equity stock in GSK, and was employed at GSK during conduct of the study; MLM and LS are employees of Health Research Associates, which received funding from GSK to conduct the study, but have no other conflict of interest to report. DJ received consultancy fees from GSK.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"2"}}